Bovine serum albumin and insulin-dependent diabetes mellitus; is cow's milk still a possible toxicological causative agent of diabetes?

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Deryck R Persaud, Alma Barranco-Mendoza


The implication of bovine serum albumin (BSA) in cow's milk as a causative agent for the onset of insulin-dependent diabetes mellitus (IDDM) is a major topic of scientific debate not withstanding the medical and economic implications. A critical survey of the pertinent literature has revealed a number of controversies. For example, an important toxicological aspect of BSA is the presence of ABBOS, a peptide segment of the protein. However, the nature and effect of ABBOS on the death of insulin producing cells (beta-cells of the pancreas) is unclear and hence inconclusive. In addition, studies in diabetes-prone mice and rats appear to show that cow's milk does not alter the frequency of diabetes in these organisms. It is suggested that BSA may not be the cause of diabetes. Instead, IDDM is most likely the result of oxidative stress, due to high local levels of nitric oxide (NO*) and oxygen radicals (O2*-), on the beta-cells of the pancreas, which eventually leads to their destruction.


Oct 13, 2007·Annals of Neurology·Brenda BanwellWadsworth Pediatric Multiple Sclerosis Study Group
Nov 19, 2013·Critical Reviews in Food Science and Nutrition·Isabelle M E Lacroix, Eunice C Y Li-Chan
Aug 6, 2014·Colloids and Surfaces. B, Biointerfaces·Quazi T H ShubhraTivadar Feczkó
Oct 19, 2018·Frontiers in Immunology·Josephine NehringMarten Trendelenburg


Jul 30, 1992·The New England Journal of Medicine·J KarjalainenH M Dosch
Nov 1, 1992·The Journal of Pediatrics·R E Kleinman
Sep 17, 1992·Nature·A G Baxter, A Cooke
Nov 1, 1991·Diabetes Care·K Dahl-JørgensenK F Hanssen
Apr 1, 1990·Immunology Today·J A Todd
Sep 1, 1990·Immunology Today·G T Nepom
Apr 1, 1984·Diabetologia·R B Elliott, J M Martin
Jul 1, 1995·Immunology Today·J F Bach
Apr 1, 1995·Immunology Today·H KolbB O Roep
Oct 21, 1994·Biochimica Et Biophysica Acta·I MiyazakiH M Dosch
Nov 24, 1994·The New England Journal of Medicine·M A Atkinson, N K Maclaren
Jun 1, 1994·Diabetes Care·G S Eisenbarth
Mar 1, 1994·Journal of the American Dietetic Association·W C MonteL E Roll
Jan 1, 1993·Critical Reviews in Food Science and Nutrition·C V Morr, E Y Ha
Dec 16, 1993·The New England Journal of Medicine·M A AtkinsonN K Maclaren
Nov 14, 1997·Diabetes·J A PaxsonA Kulczycki
Apr 12, 2001·Clinical and Experimental Immunology·C HilgerF Hentges

Related Concepts

Diabetes Mellitus, Non-Insulin-Dependent
Immune Response
Immune System
Mononuclear Cells
Virus Diseases
Glycine max
Benign Tumor of Pancreas
Bos taurus
Human leukocyte interferon

Related Feeds

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.